Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitis
- First Posted Date
- 2022-08-04
- Last Posted Date
- 2022-08-04
- Lead Sponsor
- CAGE Bio Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05487963
An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection
- Conditions
- Interventions
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- CAGE Bio Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT05202366
- Locations
- ๐บ๐ธ
John Peter Smith Hospital, Fort Worth, Texas, United States
CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- CAGE Bio Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT04886739
- Locations
- ๐บ๐ธ
Cage Bio Investigative Site 1, Fremont, California, United States
CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes
- First Posted Date
- 2020-08-11
- Last Posted Date
- 2020-08-12
- Lead Sponsor
- CAGE Bio Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT04508205
- Locations
- ๐บ๐ธ
Cage Bio Investigative Site 3, Edgewater, Florida, United States
๐บ๐ธCage Bio Investigative Site 1, Fremont, California, United States
๐บ๐ธCage Bio Investigative Site 2, San Diego, California, United States
CGB-400 for the Reduction of Facial Redness
- First Posted Date
- 2020-08-11
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- CAGE Bio Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04508660
- Locations
- ๐บ๐ธ
Cage Bio Investigative Site 1, Fremont, California, United States
๐บ๐ธCage Bio Investigative Site 2, San Diego, California, United States
๐บ๐ธCage Bio Investigative Site 3, Edgewater, Florida, United States
50 Human Subject Repeat Insult Patch Test
- First Posted Date
- 2020-08-04
- Last Posted Date
- 2020-08-04
- Lead Sponsor
- CAGE Bio Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT04498676
- Locations
- ๐บ๐ธ
AMA Laboratories Inc., New City, New York, United States
Clinical Evaluation of the Residual Antimicrobial Activity
- First Posted Date
- 2020-08-03
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- CAGE Bio Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04495920
- Locations
- ๐บ๐ธ
Bioscience Laboratories, Inc., Bozeman, Montana, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath